WILMINGTON, Del. & MUNICH--(BUSINESS WIRE)--JenaValve™ Technology, Inc., a medical device company specializing in developing transcatheter valve implantation (TAVI) systems, has been invited to participate in the UBS Global Life Sciences Conference in New York City next week. JenaValve CEO Helmut J. Straubinger will present for JenaValve on Tuesday, Sept. 21, at 7:30 a.m. ET at the Grand Hyatt New York.
